Godavari Biorefineries gets Chinese patent for viral infection use
In short
Godavari Biorefineries has received a patent in China for compounds used to treat viral infections. The patent covers compounds that block V-ATPase activity in cells and can be used to make medicine.
This matters because it gives the company another patent in a key market. The reporting also says it got a Japan patent a few months earlier for a cancer-treatment invention, but no link between the two is explained.
What the reporting says
Godavari Biorefineries received a Chinese patent for the use of compounds in treating viral infections. The summaries say the invention relates to inhibiting V-ATPase activity in cells and to making medicaments for viral infection treatment. CNBC TV18 added that the Chinese patent came a few months after a Japan Patent Office patent related to cancer treatment, but the reporting does not say whether the two inventions are connected commercially.
Why it matters
Godavari Biorefineries received a Chinese patent covering compounds used for treating viral infections. The summary says the invention is about inhibiting V-ATPase activity in cells and using the compounds in medicaments for that purpose. CNBC TV18 said the Chinese patent followed a Japan Patent Office patent from a few months earlier related to cancer treatment. The reporting does not state any financial effect or business plan.